Samyang Biopharmaceuticals Corporation of Seongnam-si, Gyeonggi-do at MEDICA 2017 in Düsseldorf -- MEDICA Trade Fair
Manufacturers

Samyang Biopharmaceuticals Corporation

295 Pangyo-ro, Bundang-gu, 13488 Seongnam-si, Gyeonggi-do
Korea, Republic

Telephone +82 2 21579833
Fax +82 2 21579062
hongsik.kim@samyang.com

Hall map

MEDICA 2017 hall map (Hall 5): stand L11

Fairground map

MEDICA 2017 fairground map: Hall 5

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.08  Surgery and Endoscopy
  • 01.08.02  Surgical instruments and products

Surgical instruments and products

  • 01  Electromedical equipment / Medical Technology
  • 01.08  Surgery and Endoscopy
  • 01.08.02  Surgical instruments and products
  • 01.08.02.08  Surgical suture materials

Our products

Product category: Surgical suture materials

Trisorb® / Trisorb®Ⅱ

coated, braided, synthetic absorbable suture bulk material (Polyglycolic acid) (PGA)

More Less

Product category: Surgical suture materials

Trisorb® Plus

Antimicrobial agent (chlorhexidine diacetate) coated Synthetic Absorbable braided Polyglycolic acid (PGA) Suture material

More Less

Product category: Surgical instruments and products

Monolene®

Synthetic Non-Absorbable monofilament Polypropylene (PP) Suture bulk material

More Less

Product category: Surgical instruments and products

Proflex® Mesh

Partially absorbable composite mesh knitted using Segmented Pie composite monofilament, composed of a Poly
(glycolide-co-caprolactone, 75:25) (PGL-PCL) copolymer and non-absorbable polypropylene.

More Less

Product category: Surgical suture materials

Neosorb® Loop / Monosorb® Loop

a surgical instrument to be used for tying and suturing the blood vessels and tissues during endoscopic surgery.
Suture Marerial : Neosorb® (PGLA910), Monosorb® (PDO)

More Less

About us

Company details

Samyang group has identified healthcare as its key strategic business focus for the 21st century.
The Samyang Biopharm is engaged in research and development of innovative technology platforms for drug delivery and 
novel application of its expertise in biopolymers for developing biomedical devices.

The Biomedical R&D Center aims to lead the DDS(Drug Delivery System) research sector worldwide. Based on our accumulated experience in synthetic synthetic resins and fine chemicals, we are continuing to closely cooperate with overseas partners and developing innovative DDS.
Thanks to Samyang Discovery Center, which was established in Seongnam Pangyo Techno Valley in April 2016, Samyang Biopharm will confirm its position as a specialized pharmaceutical company with improved R&D capability and become an R&D center that leads the sustainable growth and development of the company.

Samyang Biopharm set ‘Value Creative Pharma Company’ as its vision for 2020, which illustrates its goal to become a company that provides ‘Life’s Ingredients.

The Samyang Biopharm’s pharmaceutical plant was established in 1997 to produce premium quality active pharmaceutical ingredients(APIs) using novel plant cell culture and semisynthetic technologies. The plant was equipped in 2007 with
modern injection filling line which is dedicated to produce anti-cancer injectables.
The Biopharmaceutical plant is Korean GMP compliant and passed inspection of German and Japanese health agencies.

More Less